A game-changer for extending life expectancy. The Gilead and Tempus AI Collaboration.

Tempus AI (Nasdaq: TEM) manages one of the largest libraries of clinical records. They use their vast amount of data to identify mutations to target disease and connect the right patients to life-saving clinical trials via AI. The future of medicine is data-driven. 📈 Brian Gahsman, CIO of Contego Capital and portfolio manager of the AlphaCentric Robotics & Automation Fund discusses this ground breaking collaboration.